welcome Welcome

“May all be happy, may all be healed, may all be at peace and may no one ever suffer."


Loading...

Mitomycin C

Reserved
Cytotoxic Chemotherapy
0.00 (0)


Action Period: ...

Mitomycin is an antineoplastic antibiotic which is enzymatically reduced to its active metabolite within susceptible cells. The active metabolite appears to cause cross-linking of DNA (primarily with guanine and cytosine pairs). It is also active against gm+ve bacteria and some viruses.


Generic for Diseases

Generic Indications
  • Bladder carcinoma
  • Carcinoma
  • Cervical cancer
  • Metastatic breast carcinoma
  • Pancreatic cancer
  • Stomach carcinoma
  • Urothelial bladder carcinoma

Complement Generics
Similar Generics
Inimical Generics

Component

Drug Indications

This is indicated in Diabetic foot infections; Chronic lymphatic leukaemia; Chronic myelogenous leukaemia; Gastric, Colorectal, Lung, Pancreatic, Cervix, Endometrium, Breast, Bladder, Head & neck carcinoma.


Dosage Administration

Solid tumours Suggested regimen: Initial: 10-20 mg/m2; may repeat 6-8 wkly depending on blood count. Do not repeat if leucocyte and platelet counts are below acceptable levels. Do not re-administer if the nadir of the leucocyte count is <2,000 cells/mm3

Intravesical Superficial bladder tumours: Instill 10-40 mg 1 -3 times/wk for a total of 20 doses

Prevention of recurrent bladder tumours: Instill 20 mg 2 wkly or 40 mg 1-3-mthly.


Contraindication

Hypersensitivity. Patient with platelet counts <100,000/mm3, leukocyte counts <4,000/mm3 or serum creatinine concentration >1.7 mg/dL. Patient with substantial prolongation of prothrombin time or bleeding time, coagulation disorders, increased bleeding tendency. Pregnancy and lactation.


Side Effect

Hemolytic uremic syndrome (<15%), Myelosuppression (64%), Nausea/ vomiting (14%), Fever (14%), Stomatitis (4%), Increased serum creatinine (2%), Mucous membrane toxicity (4%) , Fatigue, Pulmonary toxicity, Dyspnea, Cystitis, Interstitial fibrosis, Nephrotoxicity, Amenorrhea, Alopecia, Myelosuppression, haemolytic-uraemic syndrome.




Precaution Warning

Repeated haematologic studies are necessary during treatment and for at least 7 wk after discontinuation of the drug. Discontinue use when the leucocyte count decreases to <4000/mm3 or the platelet count decreases to <150,000/mm3 or if a progressive decline in either occurs. Monitor patient for signs of renal or pulmonary toxicity.

Pregnancy & Lactation

Pregnancy category- D





Store

Mitomycin C

There is a list and complete profile of all allopathic generics available in the country where users can make various comments and give ratings. Generic similar to a generic, antagonistic generic, generic instructions, dosage administration, directions, side effects, warnings, ingredients, etc. have been added.

...
Racecadotril
Gastrointestinal System Drugs
...
Perindopril Arginine + Amlodipine
Cardiovascular System Drugs
...
Sanjivani Rasayan
Herbal and Nutraceuticals
...
Sulphamethoxazole + Trimethoprim
Antimicrobial drugs
...
Rehmin
Herbal and Nutraceuticals
...
Bacitracin Zinc + Polymyxin B Sulfa...
Eye preparations
...
Sodium Hyaluronate (Injection)
Bone Formation & Bone Disorders
...
Degarelix Acetate
Endocrine & Metabolic System Drugs

Searching Keywords Idea
...

Bangladesh is Number One in Digital Medical Management.
To be happy, beautiful, healthy, wealthy, hale and long-lived stay with DM3S.